Pharmaceutical Commercial Launch Readiness, Secrets to De-Risk and Accelerate Success

Commercial launch readiness is a critical stage in a product life cycle. While the world hangs on pharma’s ability to discover a COVID cure or vaccine, the global economic downturn will only increase price pressures overall for the industry. The era of increasing competitive and price pressure is not going away and capturing full value from every product launch is critical. However, history shows that only a third of product launches meet analyst expectations. Teams with the ability to optimize commercial launch readiness through insight, differentiation, efficiency, and risk mitigation will lead the pack.

Often teams, whether in a start-up, mid, or large pharma, lack extensive experience in commercial launch readiness. This influences the brand’s ability to meet forecast and achieve market access targets. Leveraging the breadth and depth of launch experience from dozens of launches across primary care, rare disease, oncology and specialty, this webinar will discuss typical commercial launch readiness risk areas, best practices approaches for commercial readiness and securing market access, and measurement.

 

Speakers: Beth Schurman and David Rees

Date: Thursday, August 6, 2020